DK2431376T4 - Ny stabilt krystal af 1-(2'-cyano-2'-deoxy-ß-D-arabinofuranosyl)cytosinmonohydrochlorid - Google Patents
Ny stabilt krystal af 1-(2'-cyano-2'-deoxy-ß-D-arabinofuranosyl)cytosinmonohydrochlorid Download PDFInfo
- Publication number
- DK2431376T4 DK2431376T4 DK10774734.7T DK10774734T DK2431376T4 DK 2431376 T4 DK2431376 T4 DK 2431376T4 DK 10774734 T DK10774734 T DK 10774734T DK 2431376 T4 DK2431376 T4 DK 2431376T4
- Authority
- DK
- Denmark
- Prior art keywords
- arabinofuranosyl
- deoxy
- cyano
- stable crystal
- new stable
- Prior art date
Links
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 title 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- 229940104302 cytosine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009118726 | 2009-05-15 | ||
| PCT/JP2010/003261 WO2010131475A1 (ja) | 2009-05-15 | 2010-05-14 | １－（２'－シアノ－２'－デオキシ－β－Ｄ－アラビノフラノシル）シトシン・一塩酸塩の新規安定形結晶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK2431376T3 DK2431376T3 (da) | 2013-09-02 |
| DK2431376T4 true DK2431376T4 (da) | 2024-02-26 |
Family
ID=43084859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10774734.7T DK2431376T4 (da) | 2009-05-15 | 2010-05-14 | Ny stabilt krystal af 1-(2'-cyano-2'-deoxy-ß-D-arabinofuranosyl)cytosinmonohydrochlorid |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8377905B2 (da) |
| EP (1) | EP2431376B2 (da) |
| JP (2) | JP5801715B2 (da) |
| KR (1) | KR101414888B1 (da) |
| CN (1) | CN102414216B (da) |
| DK (1) | DK2431376T4 (da) |
| ES (1) | ES2426025T5 (da) |
| FI (1) | FI2431376T4 (da) |
| HR (1) | HRP20131090T4 (da) |
| PL (1) | PL2431376T3 (da) |
| PT (1) | PT2431376E (da) |
| RU (1) | RU2538593C2 (da) |
| WO (1) | WO2010131475A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| MX352423B (es) * | 2012-03-28 | 2017-11-24 | Fujifilm Corp | Sal de 1-(2-desoxi-2-fluoro-4-tio-beta-d-arabinofuranosil) citosina. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
| FI105556B (fi) * | 1991-09-30 | 2000-09-15 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta |
| US5637688A (en) * | 1994-12-13 | 1997-06-10 | Eli Lilly And Company | Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride |
| GB0526419D0 (en) * | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
-
2010
- 2010-05-14 RU RU2011146144/04A patent/RU2538593C2/ru active
- 2010-05-14 EP EP10774734.7A patent/EP2431376B2/en active Active
- 2010-05-14 WO PCT/JP2010/003261 patent/WO2010131475A1/ja active Application Filing
- 2010-05-14 CN CN201080017920.4A patent/CN102414216B/zh active Active
- 2010-05-14 DK DK10774734.7T patent/DK2431376T4/da active
- 2010-05-14 PT PT107747347T patent/PT2431376E/pt unknown
- 2010-05-14 US US13/264,111 patent/US8377905B2/en active Active
- 2010-05-14 FI FIEP10774734.7T patent/FI2431376T4/fi active
- 2010-05-14 ES ES10774734T patent/ES2426025T5/es active Active
- 2010-05-14 JP JP2011513251A patent/JP5801715B2/ja active Active
- 2010-05-14 PL PL10774734T patent/PL2431376T3/pl unknown
- 2010-05-14 KR KR1020117027019A patent/KR101414888B1/ko active IP Right Grant
-
2013
- 2013-11-14 HR HRP20131090TT patent/HRP20131090T4/hr unknown
-
2015
- 2015-06-10 JP JP2015117232A patent/JP6307045B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2538593C2 (ru) | 2015-01-10 |
| HRP20131090T4 (hr) | 2024-03-15 |
| EP2431376A4 (en) | 2012-08-01 |
| EP2431376B2 (en) | 2024-02-07 |
| KR20120022940A (ko) | 2012-03-12 |
| ES2426025T5 (es) | 2024-06-13 |
| PT2431376E (pt) | 2013-09-17 |
| HRP20131090T1 (hr) | 2013-12-20 |
| CN102414216A (zh) | 2012-04-11 |
| JP2015157867A (ja) | 2015-09-03 |
| CN102414216B (zh) | 2015-01-21 |
| US8377905B2 (en) | 2013-02-19 |
| PL2431376T3 (pl) | 2014-01-31 |
| EP2431376A1 (en) | 2012-03-21 |
| ES2426025T3 (es) | 2013-10-18 |
| JP5801715B2 (ja) | 2015-10-28 |
| EP2431376B1 (en) | 2013-08-14 |
| KR101414888B1 (ko) | 2014-07-03 |
| JPWO2010131475A1 (ja) | 2012-11-01 |
| FI2431376T4 (fi) | 2024-03-13 |
| RU2011146144A (ru) | 2013-06-20 |
| JP6307045B2 (ja) | 2018-04-04 |
| US20120029182A1 (en) | 2012-02-02 |
| WO2010131475A1 (ja) | 2010-11-18 |
| DK2431376T3 (da) | 2013-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2848610T3 (da) | Hæmmere af kinaseaktivitet | |
| DK2117523T3 (da) | Inhibitorer af AKT-aktivitet | |
| DK2187845T3 (da) | Korrektion af fejlformede ører | |
| DK2318396T3 (da) | Krystalform af posaconazol | |
| DK3208269T3 (da) | Inhibitorer af c-fms-kinase | |
| DK2182950T3 (da) | Anvendelse af 4-(pyrrolidin-1-yl)quinolinforbindelser til at dræbe klinisk latente mikroorganismer | |
| DE602007003881D1 (de) | Intraperikardiale Elektrode | |
| DK2234485T3 (da) | Stabile laquinimod-præparater | |
| DK2300461T3 (da) | Cycliske inhibitorer af 11beta-hydroxysteroid-dehydrogenase 1 | |
| DK2700786T3 (da) | Modifikation af overførselspassage | |
| FR2948584B1 (fr) | Embout d'application | |
| DK2470518T3 (da) | Esterderivater af 2,5-furandicarboxylsyre og deres anvendelse som blødgørere | |
| DK2211901T3 (da) | Vaccination med multiple clader af h5-influenza-a-virus | |
| DK1981859T3 (da) | Fremstilling af delmopinol | |
| FI20075532A (fi) | Uusia esteraaseja ja niiden käyttö | |
| DK3225251T3 (da) | Modulering af pro-neurotrofinaktivitet | |
| DK2219469T3 (da) | Modificering af enzymatisk disponerede proteiner | |
| ATE478849T1 (de) | 4-anilinochinolin-3-carbonsäureamide als csf-1r- kinaseinhibitoren | |
| DK2202225T3 (da) | Ny fremgangsmåde til syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre | |
| DK2262793T3 (da) | Krystallinske former af nilotinib-hci | |
| DK2021330T3 (da) | Benzimidazolmodulatorer af VR1 | |
| DK2091945T3 (da) | Nye inhibitorer af glutaminylcyclase | |
| DK2111555T3 (da) | Diagnosticering af præeklampsi | |
| DK2083629T3 (da) | Krystallinsk modifikation af fipronil | |
| DK2114147T3 (da) | Reduktion af bivirkninger af tramadol |